Sorry I was switching topics in the same paragraph the Oral comment was in regard to their delivery of proteins that they claim (from the slide presentation I think I saw a slide on doing it in Gaucher). Speaking of being down I still can't get a replay of their analyst day webcast can you pull strings to get a replay of their webcast up :-).
(KMDA/PLX/MNTA)—Your exchange regarding KMDA’s inhaled AAT drug reminds me of a post you made almost five years ago in #msg-32783294; this is the header:
Plasma Product Companies Outmuscle Small Recombinant Players
To a large degree, the above statement still pertains. MNTA’s sialylated-IVIG program could eventually face this issue depending on whether MNTA decides to cooperate with a plasma company (possibly, but not necessarily, BAX) or to compete against the plasma companies with a recombinant product.
Market Data 
Markets 
AI
